SCHEMBL4428196

SCHEMBL4428196

Cc1cn([C@@H]2O[C@H](C(O)Cl)[C@@H](O)[C@H]2O)c(=O)nc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.43
▸ MTOR P42345 2/20 0.43
▸ BLM P54132 2/20 0.43
▸ NT5E P21589 1/20 0.43
▸ GMNN O75496 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ DNMT1 P26358 1/20 0.43
▸ THPO P40225 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ HBB P68871 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ ADK P55263 1/20 0.39
▸ ADORA3 P0DMS8 3/20 0.38
▸ THRB P10828 2/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23098378 0.82 ADK (0.56) LMNAMTORHBBPMP22ADK
SCHEMBL15855041 0.81 NT5E (0.40) NT5EADK
SCHEMBL16629487 0.80 LMNA (0.50) LMNAMTORBLMGMNNALDH1A1
SCHEMBL21275623 0.80 LMNA (0.50) LMNAMTORBLMGMNNALDH1A1
SCHEMBL5888717 0.79 ALDH1A1 (0.38) LMNAMTORNT5EALDH1A1HTT
SCHEMBL41572 0.79 LMNA (0.62) LMNAMTORBLMGMNNALDH1A1
SCHEMBL2579580 0.79 LMNA (0.62) LMNAMTORBLMGMNNALDH1A1
SCHEMBL5888462 0.79 LMNA (0.49) LMNAMTORBLMGMNNALDH1A1
SCHEMBL14441083 0.79 LMNA (0.62) LMNAMTORBLMGMNNALDH1A1
SCHEMBL18512948 0.79 LMNA (0.62) LMNAMTORBLMGMNNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1804821-A4 HCV NS3-NS4A PROTEASE INHIBITION VERTEX PHARMA (US) 2009-07-15 — — EP disclosed
EP-1804821-A2 HCV NS3-NS4A PROTEASE INHIBITION Vertex Pharmaceuticals, Inc. (US) 2007-07-11 — — EP disclosed
WO-2006039488-A2 HCV NS3-NS4A PROTEASE INHIBITION VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-04-13 — — WO disclosed
Send feedback